Atlas Trials

Acute Leukemia of Ambiguous Lineage

22 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acute Leukemia of Ambiguous Lineage

RecordFirmDate
Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage (NCT04440267)Institute of Hematology & Blood Diseases Hospital, China2020-07-08
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation (NCT04065399)Syndax Pharmaceuticals2019-11-05
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia (NCT04067336)Kura Oncology, Inc.2019-09-12
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant (NCT03779854)Fred Hutchinson Cancer Center2019-08-29
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement (NCT02828358)National Cancer Institute (NCI)2017-04-01
Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm (NCT03012672)University of Washington2016-12-30
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD (NCT02220985)Fred Hutchinson Cancer Center2015-03-23
Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia (NCT02135874)M.D. Anderson Cancer Center2014-10-27
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children (NCT01858740)Fred Hutchinson Cancer Center2014-04-10
Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01701323)Nohla Therapeutics, Inc.2012-12-10
POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients (NCT01319864)Seattle Children's Hospital2011-03-01

Track Acute Leukemia of Ambiguous Lineage automatically

Every clearance here is in the API, with alerts when new ones post.